ID   PPAT_HUMAN              Reviewed;         426 AA.
AC   Q9BZG2; C0H3P7; Q9BZG3; Q9BZG4;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 132.
DE   RecName: Full=Testicular acid phosphatase {ECO:0000305};
DE            EC=3.1.3.2;
DE   AltName: Full=Acid phosphatase 4 {ECO:0000312|HGNC:HGNC:14376};
DE   Flags: Precursor;
GN   Name=ACP4 {ECO:0000312|HGNC:HGNC:14376};
GN   Synonyms=ACPT {ECO:0000303|PubMed:11414767, ECO:0000312|HGNC:HGNC:14376};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3), INDUCTION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11414767; DOI=10.1006/geno.2001.6556;
RA   Yousef G.M., Diamandis M., Jung K., Diamandis E.P.;
RT   "Molecular cloning of a novel human acid phosphatase gene (ACPT) that is
RT   highly expressed in the testis.";
RL   Genomics 74:385-395(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, AND GLYCOSYLATION.
RC   TISSUE=Testis;
RX   PubMed=15219672; DOI=10.1016/j.neuroscience.2004.04.060;
RA   Fleisig H., El-Din El-Husseini A., Vincent S.R.;
RT   "Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid
RT   phosphatase.";
RL   Neuroscience 127:91-100(2004).
RN   [3]
RP   INVOLVEMENT IN AI1J, VARIANTS AI1J CYS-76; CYS-111; PRO-128; LYS-133 AND
RP   LEU-238, AND FUNCTION.
RX   PubMed=27843125; DOI=10.1016/j.ajhg.2016.09.018;
RA   Seymen F., Kim Y.J., Lee Y.J., Kang J., Kim T.H., Choi H., Koruyucu M.,
RA   Kasimoglu Y., Tuna E.B., Gencay K., Shin T.J., Hyun H.K., Kim Y.J.,
RA   Lee S.H., Lee Z.H., Zhang H., Hu J.C., Simmer J.P., Cho E.S., Kim J.W.;
RT   "Recessive mutations in ACPT, encoding testicular acid phosphatase, cause
RT   hypoplastic amelogenesis imperfecta.";
RL   Am. J. Hum. Genet. 99:1199-1205(2016).
CC   -!- FUNCTION: May dephosphorylate receptor tyrosine-protein kinase ERBB4
CC       and inhibits its ligand-induced proteolytic cleavage (PubMed:15219672).
CC       May play a role in odontogenesis (PubMed:27843125).
CC       {ECO:0000269|PubMed:15219672, ECO:0000269|PubMed:27843125}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a phosphate monoester + H2O = an alcohol + phosphate;
CC         Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.2;
CC   -!- SUBUNIT: Homodimer. {ECO:0000305|PubMed:15219672}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass type I
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BZG2-1; Sequence=Displayed;
CC       Name=2; Synonyms=Variant 3;
CC         IsoId=Q9BZG2-2; Sequence=VSP_021494;
CC       Name=3; Synonyms=Truncated variant 1, Truncated variant 2;
CC         IsoId=Q9BZG2-3; Sequence=VSP_021493, VSP_021495;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the testis. Also expressed in
CC       the brain where they are enriched at the postsynaptic sites. Expressed
CC       at lower levels in the trachea, prostate, bone marrow, spinal cord,
CC       colon, fetal brain, heart, thymus, fetal liver, spleen, leukocytes,
CC       ovary, small intestine, pancreas and skeletal muscle. Expression is
CC       significantly lower in testicular cancer tissues than in normal
CC       testicular tissues. Isoform 3 is expressed in the testis, trachea,
CC       prostate and bone marrow. {ECO:0000269|PubMed:11414767}.
CC   -!- INDUCTION: Up-regulated by mibolerone (a synthetic androgen) and
CC       dihydrotestosterone (DHT) and is down-regulated by estrogen and
CC       progestin. {ECO:0000269|PubMed:11414767}.
CC   -!- PTM: Glycosylated. {ECO:0000305|PubMed:15219672}.
CC   -!- DISEASE: Amelogenesis imperfecta 1J (AI1J) [MIM:617297]: A form of
CC       amelogenesis imperfecta, a disorder characterized by defective enamel
CC       formation. The enamel may be hypoplastic, hypomineralized or both, and
CC       affected teeth may be discoloured, sensitive or prone to
CC       disintegration. AI1J is an autosomal recessive form characterized by
CC       hypoplastic enamel, enamel discolorization ranging from yellow to
CC       black, and normal dentin. {ECO:0000269|PubMed:27843125}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF321918; AAK09393.1; -; Genomic_DNA.
DR   EMBL; AF321918; AAK09394.1; -; Genomic_DNA.
DR   EMBL; AF321918; AAK09395.1; -; Genomic_DNA.
DR   EMBL; AF321918; AAK09396.1; -; Genomic_DNA.
DR   CCDS; CCDS12802.1; -. [Q9BZG2-1]
DR   RefSeq; NP_149059.1; NM_033068.2. [Q9BZG2-1]
DR   SMR; Q9BZG2; -.
DR   STRING; 9606.ENSP00000270593; -.
DR   DEPOD; ACP4; -.
DR   GlyGen; Q9BZG2; 4 sites.
DR   iPTMnet; Q9BZG2; -.
DR   PhosphoSitePlus; Q9BZG2; -.
DR   BioMuta; ACP4; -.
DR   DMDM; 74717749; -.
DR   PaxDb; Q9BZG2; -.
DR   PeptideAtlas; Q9BZG2; -.
DR   PRIDE; Q9BZG2; -.
DR   ProteomicsDB; 79839; -. [Q9BZG2-1]
DR   ProteomicsDB; 79840; -. [Q9BZG2-2]
DR   ProteomicsDB; 79841; -. [Q9BZG2-3]
DR   TopDownProteomics; Q9BZG2-2; -. [Q9BZG2-2]
DR   Antibodypedia; 32366; 78 antibodies.
DR   DNASU; 93650; -.
DR   Ensembl; ENST00000270593; ENSP00000270593; ENSG00000142513. [Q9BZG2-1]
DR   GeneID; 93650; -.
DR   KEGG; hsa:93650; -.
DR   UCSC; uc002pta.1; human. [Q9BZG2-1]
DR   CTD; 93650; -.
DR   DisGeNET; 93650; -.
DR   GeneCards; ACP4; -.
DR   HGNC; HGNC:14376; ACP4.
DR   HPA; ENSG00000142513; Tissue enhanced (skin, testis).
DR   MalaCards; ACP4; -.
DR   MIM; 606362; gene.
DR   MIM; 617297; phenotype.
DR   neXtProt; NX_Q9BZG2; -.
DR   OpenTargets; ENSG00000142513; -.
DR   Orphanet; 100031; Hypoplastic amelogenesis imperfecta.
DR   PharmGKB; PA24450; -.
DR   VEuPathDB; HostDB:ENSG00000142513.5; -.
DR   eggNOG; KOG3720; Eukaryota.
DR   GeneTree; ENSGT00940000161433; -.
DR   HOGENOM; CLU_030431_1_1_1; -.
DR   InParanoid; Q9BZG2; -.
DR   OMA; ADWKPIP; -.
DR   OrthoDB; 1221585at2759; -.
DR   PhylomeDB; Q9BZG2; -.
DR   TreeFam; TF312893; -.
DR   PathwayCommons; Q9BZG2; -.
DR   BioGRID-ORCS; 93650; 6 hits in 979 CRISPR screens.
DR   GenomeRNAi; 93650; -.
DR   Pharos; Q9BZG2; Tbio.
DR   PRO; PR:Q9BZG2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9BZG2; protein.
DR   Bgee; ENSG00000142513; Expressed in amniotic fluid and 125 other tissues.
DR   Genevisible; Q9BZG2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IBA:GO_Central.
DR   GO; GO:0003993; F:acid phosphatase activity; IBA:GO_Central.
DR   GO; GO:0016791; F:phosphatase activity; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IDA:UniProtKB.
DR   GO; GO:0016311; P:dephosphorylation; IBA:GO_Central.
DR   GO; GO:0007040; P:lysosome organization; IBA:GO_Central.
DR   GO; GO:0120154; P:negative regulation of ERBB4 signaling pathway; IDA:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB.
DR   GO; GO:0042476; P:odontogenesis; IMP:UniProtKB.
DR   GO; GO:1990264; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IDA:UniProtKB.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
DR   PROSITE; PS00778; HIS_ACID_PHOSPHAT_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amelogenesis imperfecta; Disease variant;
KW   Disulfide bond; Glycoprotein; Hydrolase; Membrane; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..426
FT                   /note="Testicular acid phosphatase"
FT                   /id="PRO_0000259643"
FT   TOPO_DOM        27..393
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        394..414
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        415..426
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        41
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P15309"
FT   ACT_SITE        289
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P15309"
FT   CARBOHYD        191
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        269
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        330
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        339
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        159..378
FT                   /evidence="ECO:0000250|UniProtKB:P15309"
FT   DISULFID        214..312
FT                   /evidence="ECO:0000250|UniProtKB:P15309"
FT   DISULFID        353..357
FT                   /evidence="ECO:0000250|UniProtKB:P15309"
FT   VAR_SEQ         39..92
FT                   /note="FRHGDRAPLASYPMDPHKEVASTLWPRGLGQLTTEGVRQQLELGRFLRSRYE
FT                   AF -> RRPHPGLPLAPPGLALTSPVPRYSAMATGPRWPPTPWTHTRRWPPPCGHEAWA
FT                   S (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_021493"
FT   VAR_SEQ         91..183
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_021494"
FT   VAR_SEQ         93..426
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_021495"
FT   VARIANT         76
FT                   /note="R -> C (in AI1J; dbSNP:rs1057519277 and
FT                   dbSNP:rs902112287)"
FT                   /evidence="ECO:0000269|PubMed:27843125"
FT                   /id="VAR_078014"
FT   VARIANT         111
FT                   /note="R -> C (in AI1J; dbSNP:rs202073531)"
FT                   /evidence="ECO:0000269|PubMed:27843125"
FT                   /id="VAR_078015"
FT   VARIANT         128
FT                   /note="A -> P (in AI1J; unknown pathological significance;
FT                   dbSNP:rs767907487)"
FT                   /evidence="ECO:0000269|PubMed:27843125"
FT                   /id="VAR_078016"
FT   VARIANT         133
FT                   /note="E -> K (in AI1J; unknown pathological significance;
FT                   dbSNP:rs779823931)"
FT                   /evidence="ECO:0000269|PubMed:27843125"
FT                   /id="VAR_078017"
FT   VARIANT         238
FT                   /note="S -> L (in AI1J; dbSNP:rs763573828)"
FT                   /evidence="ECO:0000269|PubMed:27843125"
FT                   /id="VAR_078018"
SQ   SEQUENCE   426 AA;  46090 MW;  BE930398041DB061 CRC64;
     MAGLGFWGHP AGPLLLLLLL VLPPRALPEG PLVFVALVFR HGDRAPLASY PMDPHKEVAS
     TLWPRGLGQL TTEGVRQQLE LGRFLRSRYE AFLSPEYRRE EVYIRSTDFD RTLESAQANL
     AGLFPEAAPG SPEARWRPIP VHTVPVAEDK LLRFPMRSCP RYHELLREAT EAAEYQEALE
     GWTGFLSRLE NFTGLSLVGE PLRRAWKVLD TLMCQQAHGL PLPAWASPDV LRTLAQISAL
     DIGAHVGPPR AAEKAQLTGG ILLNAILANF SRVQRLGLPL KMVMYSAHDS TLLALQGALG
     LYDGHTPPYA ACLGFEFRKH LGNPAKDGGN VTVSLFYRND SAHLPLPLSL PGCPAPCPLG
     RFYQLTAPAR PPAHGVSCHG PYEAAIPPAP VVPLLAGAVA VLVALSLGLG LLAWRPGCLR
     ALGGPV
//
